IN2014DN11112A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN11112A IN2014DN11112A IN11112DEN2014A IN2014DN11112A IN 2014DN11112 A IN2014DN11112 A IN 2014DN11112A IN 11112DEN2014 A IN11112DEN2014 A IN 11112DEN2014A IN 2014DN11112 A IN2014DN11112 A IN 2014DN11112A
- Authority
- IN
- India
- Prior art keywords
- formula
- alzheimer
- definitions
- disease
- prevention
- Prior art date
Links
- 108090000371 Esterases Proteins 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 150000005528 benzodioxoles Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210226125.7A CN103524515B (zh) | 2012-07-03 | 2012-07-03 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
| PCT/CN2013/000813 WO2014005421A1 (zh) | 2012-07-03 | 2013-07-03 | 苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN11112A true IN2014DN11112A (de) | 2015-09-25 |
Family
ID=49881293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN11112DEN2014 IN2014DN11112A (de) | 2012-07-03 | 2013-07-03 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9346818B2 (de) |
| EP (1) | EP2871184B1 (de) |
| JP (1) | JP6113275B2 (de) |
| KR (1) | KR101650776B1 (de) |
| CN (2) | CN103524515B (de) |
| AU (1) | AU2013286523B2 (de) |
| BR (1) | BR112014032964A2 (de) |
| CA (1) | CA2878000C (de) |
| CL (1) | CL2014003607A1 (de) |
| DK (1) | DK2871184T3 (de) |
| EA (1) | EA026210B1 (de) |
| ES (1) | ES2645643T3 (de) |
| IL (1) | IL236395A (de) |
| IN (1) | IN2014DN11112A (de) |
| MX (1) | MX357774B (de) |
| MY (1) | MY167075A (de) |
| NO (1) | NO2871184T3 (de) |
| NZ (1) | NZ703549A (de) |
| PE (1) | PE20150349A1 (de) |
| PH (1) | PH12015500012B1 (de) |
| PT (1) | PT2871184T (de) |
| SG (1) | SG11201500007WA (de) |
| UA (1) | UA113444C2 (de) |
| WO (1) | WO2014005421A1 (de) |
| ZA (1) | ZA201500692B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103524515B (zh) * | 2012-07-03 | 2016-07-06 | 浙江海正药业股份有限公司 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
| CN105859732B (zh) * | 2016-04-11 | 2018-04-06 | 浙江海正药业股份有限公司 | 制备ad‑35的工艺 |
| JP2019515052A (ja) * | 2016-05-13 | 2019-06-06 | デルノバ・インコーポレイテッドＤｅｌＮｏｖａ，Ｉｎｃ． | 化学的除神経から生じる副作用の処置 |
| CN110812358B (zh) * | 2018-08-10 | 2022-04-05 | 浙江海正药业股份有限公司 | 化合物ad-35在治疗与胃肠蠕动障碍相关疾病中的应用 |
| CN113185447B (zh) * | 2021-05-06 | 2023-07-21 | 四川大学 | 邻苯二甲酰半胱酰胺类化合物、其制备方法和用途 |
| WO2023116915A1 (zh) * | 2021-12-24 | 2023-06-29 | 珠海市藤栢医药有限公司 | AChE/SERT双靶点抑制剂及其制备方法和用途 |
| CN120172986A (zh) * | 2023-12-19 | 2025-06-20 | 浙江海正药业股份有限公司 | Ad-35多晶型物及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087541A (en) * | 1975-03-06 | 1978-05-02 | Boehringer Ingelheim Gmbh | 2-(Aralkylaminoalkyl)phthalimidines |
| US5175157A (en) * | 1985-11-27 | 1992-12-29 | Boehringer Ingelheim Gmbh | Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JPH0610496B2 (ja) * | 1987-09-17 | 1994-02-09 | ダイハツ工業株式会社 | 車両用自動変速機のクラッチ構造 |
| JP2777159B2 (ja) * | 1988-12-22 | 1998-07-16 | エーザイ株式会社 | 環状アミン誘導体を含有する医薬 |
| IL125809A (en) | 1998-08-17 | 2005-08-31 | Finetech Lab Ltd | Process and intermediates for production of donepezil and related compounds |
| IL151533A0 (en) * | 2000-02-29 | 2003-04-10 | Mitsubishi Pharma Corp | Novel cyclic amide derivatives |
| EP1468684A4 (de) * | 2002-01-22 | 2008-02-27 | Eisai R&D Man Co Ltd | Sigma-rezeptor-bindungsmolekül mit indanonderivat |
| EP1654230A1 (de) | 2003-07-01 | 2006-05-10 | Hetero Drugs Limited | Herstellung von zwischenprodukten für acetylcholinesteraseinhibitoren |
| WO2005076749A2 (en) | 2004-02-11 | 2005-08-25 | Jubilant Organosys Limited | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine |
| KR20080085195A (ko) | 2006-01-04 | 2008-09-23 | 씨아이피엘에이 엘티디. | 도네페질의 제조방법 및 중간체 |
| ATE460404T1 (de) | 2006-01-18 | 2010-03-15 | Siena Biotech Spa | Modulatoren von alpha7-nikotin-acetylcholin- rezeptoren und therapeutische anwendungen davon |
| EP2114166A4 (de) * | 2006-12-11 | 2011-05-25 | Reviva Pharmaceuticals Inc | Zusammensetzungen, synthese und verfahren zur verwendung indanonbasierter cholinesterase-hemmer |
| CN103524515B (zh) * | 2012-07-03 | 2016-07-06 | 浙江海正药业股份有限公司 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
-
2012
- 2012-07-03 CN CN201210226125.7A patent/CN103524515B/zh active Active
-
2013
- 2013-03-07 UA UAA201500866A patent/UA113444C2/uk unknown
- 2013-07-03 KR KR1020157002550A patent/KR101650776B1/ko not_active Expired - Fee Related
- 2013-07-03 EA EA201590074A patent/EA026210B1/ru not_active IP Right Cessation
- 2013-07-03 IN IN11112DEN2014 patent/IN2014DN11112A/en unknown
- 2013-07-03 MY MYPI2014704095A patent/MY167075A/en unknown
- 2013-07-03 AU AU2013286523A patent/AU2013286523B2/en active Active
- 2013-07-03 SG SG11201500007WA patent/SG11201500007WA/en unknown
- 2013-07-03 CA CA2878000A patent/CA2878000C/en active Active
- 2013-07-03 DK DK13813363.2T patent/DK2871184T3/da active
- 2013-07-03 ES ES13813363.2T patent/ES2645643T3/es active Active
- 2013-07-03 PT PT138133632T patent/PT2871184T/pt unknown
- 2013-07-03 BR BR112014032964A patent/BR112014032964A2/pt not_active Application Discontinuation
- 2013-07-03 CN CN201380033665.6A patent/CN104395303B/zh active Active
- 2013-07-03 PE PE2014002581A patent/PE20150349A1/es active IP Right Grant
- 2013-07-03 EP EP13813363.2A patent/EP2871184B1/de active Active
- 2013-07-03 NO NO13813363A patent/NO2871184T3/no unknown
- 2013-07-03 MX MX2015000334A patent/MX357774B/es active IP Right Grant
- 2013-07-03 WO PCT/CN2013/000813 patent/WO2014005421A1/zh not_active Ceased
- 2013-07-03 NZ NZ703549A patent/NZ703549A/en not_active IP Right Cessation
- 2013-07-03 JP JP2015518794A patent/JP6113275B2/ja active Active
- 2013-07-03 US US14/411,783 patent/US9346818B2/en active Active
-
2014
- 2014-12-22 IL IL236395A patent/IL236395A/en not_active IP Right Cessation
- 2014-12-31 CL CL2014003607A patent/CL2014003607A1/es unknown
-
2015
- 2015-01-05 PH PH12015500012A patent/PH12015500012B1/en unknown
- 2015-01-30 ZA ZA2015/00692A patent/ZA201500692B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ762034A (en) | Human plasma kallikrein inhibitors | |
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| IN2015DN01156A (de) | ||
| ZA201701299B (en) | Glycosidase inhibitors | |
| MX2015008957A (es) | Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1). | |
| IN2014KN00948A (de) | ||
| IN2014DN03206A (de) | ||
| PH12015500012A1 (en) | Benzodioxole derivative and preparation method and use thereof | |
| NZ704863A (en) | Bicyclic pyridinones useful as gamma secretase modulators | |
| MY170922A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
| PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
| GEAP201814248A (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| GEP20186880B (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| MX2015000362A (es) | Benzo(b)-azepin-2-onas antiproliferativas. | |
| MX2021010297A (es) | Inhibidores de calicreina plasmatica humana. | |
| NZ702254A (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| PH12015500399A1 (en) | Azaindolines | |
| UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) | |
| WO2013155465A8 (en) | Substituted xanthine derivatives | |
| HK1216721A1 (zh) | 治疗肝脏疾病或病状的用途和方法 | |
| PH12015500282A1 (en) | N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug | |
| MY187891A (en) | Tetrahydropyridine derivatives as fabi inhibitors | |
| NZ780408A (en) | Human plasma kallikrein inhibitors | |
| HK1202249A1 (en) | Vesicular formulations | |
| WO2013175347A3 (en) | Compositions and methods for treatment of respiratory disorders |